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Abstract
Background: Gastro Intestinal Stromal Tumors (GISTs) are rare stromal neoplasms that
represent the most common mesenchymal tumor of the G.I. tract, accounting for 5% of all
sarcomas [1,2]. Originating from interstitial cells of Cajal, which are regulators of gut peristalsis,
they are preferentially located in the stomach and the small intestine [3] and clinical presentation
is variable, ranging from vague complaints to major G.I. bleeding. Surgical resection is the mainstay
of treatment for patients with resectable GIST and 5-year survival ranges from 21% to 88% in
different series depending on risk grading and completeness of surgical resection [4,5]. Imatinib
mesylate, a tyrosine kinase inhibitor, provides an encouraging option for treating high risk GISTs.
Case presentation: We report the case of a 62-year-old lady who had been diagnosed and being
treated unsuccessfully for Irritable bowel syndrome for 11 years and eventually found to have an
obstructing small bowel GIST.
Conclusion: The symptoms from GIST may mimic those of irritable bowel syndrome. A
physiological alteration in gut peristalsis resulting from neoplastic transformation of the interstitial
cells of Cajal, is a hypothesis that could explain this presentation. An alternative diagnosis should
be considered when treating patients with irritable bowel syndrome who fail to respond for a
prolonged period.
Case Report
A 69 year old lady presented 11 years ago with pain of
mild to moderate severity on the right side of her abdo-
men. This pain was intermittent, described as 'no more
than a dull ache' and associated with nausea, bloating and
flatulence. She also suffered from constipation and expe-
rienced partial relief of her symptoms following defeaca-
tion. She reported worsening of her symptoms after a
heavy meal, and experienced occasional bouts of steator-
rhea. Physical examination revealed mild right-sided
abdominal tenderness only.
Apart from the above she was a healthy lady without any
co morbidity and no history of previous abdominal sur-
gery. Initial investigations included an abdominal ultra-
sound scan (USS), a hepatobiliary iminodiacetic acid
(HIDA) scan and an oesophago-gastro-duodenoscopy
(OGD), which did not reveal any abnormality. Flexible
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Her pain was thought to be due to a slow transit colon and
she was advised to take laxatives on a regular basis, which
resulted in partial and temporary relief of her symptoms.
Although her condition did not impact her lifestyle signif-
icantly, her symptoms never subsided completely and
almost two years following initial presentation she under-
went an endoscopic retrograde cholangiopancreatogra-
phy (ERCP), a cream absorption test, wheat intolerance
test and a CT scan of her abdomen. All of these did not
reveal any abnormality and thus irritable bowel syndrome
was thought to represent best her condition. She was also
advised to take antispasmodics together with various
combinations of laxatives and a course of Pancrelipase
(Creon) tablets for presumed pancreatic insufficiency,
which resulted in only temporary relief.
An opinion of a gastroenterology consultant physician
was sought, resulting in another abdominal USS and
OGD, as well as a barium follow through study which
were all normal and thus she continued to take sympto-
matic treatment.
Finally, 11 years from presentation, the patient was admit-
ted to hospital with acute small bowel obstruction and
underwent a laparotomy within 24 hours of admission
after adequate fluid and electrolyte replacement. At the
operation a sizable mid-ileum, obstructing tumor was
revealed, that was wedge resected with adequate gross
margins followed by end to end hand sewn anastomosis.
The rest of the laparotomy was unremarkable with no evi-
dence of macroscopic spread of disease.
Histopathological analysis revealed a densely crowded
spindle and polygonal cell tumour showing moderate
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higher magnification respectively. The tumour consists of 
densely crowded spindle and polygonal cells with moderate 
nuclear pleomorphism. It has involved all the layers of the 
small bowel wall from mucosa outwards to the serosa.
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were found and the tumour spread into the mucosa and
outwards into the serosa. There was no lymph nodal
spread. Immunohistochemistry demonstrated positive
staining for CD117 (cKit) (figure 3), and negative staining
for broad range cytokeratins (MNF 116), CD34, desmin,
S-100 and chromogranin. Although there were no
mitoses, based on the size (80 × 40 × 50 mm), the tumour
was classified as a GIST of intermediate malignant
potential.
The patient made an uneventful recovery and remarkably,
all her previous abdominal symptoms were completely
resolved. A CT scan of the chest, abdomen and pelvis per-
formed subsequently did not reveal the presence of meta-
static disease. Her case was discussed in our
multidisciplinary team meeting and it was decided not to
proceed with any adjuvant treatment. At one year follow
up our patient was a very happy lady completely free of
her abdominal symptoms.
Discussion
Although morphologically similar to other benign and
malignant smooth muscle and neural stromal tumors,
GIST constitutes a distinct group of rare gastrointestinal
tract tumors that originate from the interstitial cells of
Cajal [6]. The latter are regulators of gut peristalsis and
normally express CD117, which is a product of the c-kit
proto-oncogene that encodes a tyrosine kinase receptor,
which regulates cellular proliferation in GISTs [1,6].
GISTs arise from the muscularis mucosa or muscularis
propria layers and most exhibit an endophytic growth pat-
tern, growing within the bowel lumen. The overlying
mucosa is usually preserved but larger and more aggres-
sive tumors tend to ulcerate through this. In up to one
third of patients the tumor invades an adjacent organ. The
vast majority of GISTs (up to 70%) arise in the stomach,
with 20–30% originating in the small intestine and the
remainder 10% occurring in the oesophagus, colon and
rectum [1,3].
The clinical presentation is variable and depends on
tumor size and anatomic site. Their submucosal location
can produce local obstructive symptoms, particularly
when arising in the oesophagus or the small intestine.
Vague upper abdominal pain, fullness, GI bleeding, pal-
pable mass are other modes of presentation whereas
sometimes they are found incidentally during barium
studies, endoscopy or abdominal scans performed for
other reasons [1]. According to some authors, visceral
obstruction is a rare occurrence even in the presence of
extensive peritoneal metastatic disease [7].
Our patient had a very long course of vague symptoms
consisting of abdominal pain, nausea, bloating and con-
stipation, which were initially attributed to impaired gut
motility as part of the irritable bowel syndrome. Her
symptoms, however, failed to improve sufficiently to any
treatment approach.
As mentioned above GIST's arise from the interstitial cells
of Cajal, which play an important role in the regulation of
gut peristalsis. Neoplastic transformation of these cells to
a GIST could possibly result in alterations of the normal,
local regulation of the gut motility. This hypothesis could,
at least in part, explain our patient's symptoms especially
at the initial stages of her presentation when the tumor
would be too small to cause mechanical obstruction.
More research into the physiology of the gut motility in
relation to a GIST tumor would be needed to support or
reject such a hypothesis.
Conclusion
The occurrence of a GIST in the small bowel can present
with vague symptoms, in our case symptoms thought to
be from IBS for 11 years. We suggest that at least in the ini-
tial years our patients' symptoms may have been the result
of functional alteration of gut peristalsis due to the
increased number of CD117 positive cells in a slow grow-
ing GIST. That would suggest that GISTs can alter the
motility of the G.I tract, even when the tumor is signifi-
cantly small and thus difficult to detect on routine inves-
tigations. The symptoms may mimic those of irritable
bowel syndrome and an alternative diagnosis should be
considered when treating patients who fail to respond for
a prolonged period. Resection of the tumour resulting in
complete resolution of her symptoms strengthens the
above suggestion. Although a diagnostic laparoscopy may
not have helped detect the tumour when very small, it
could have been considered at some stage during the years
preceding her final presentation as acute intestinal
obstruction.
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